HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Health Fraud Didn’t Start With COVID-19, Senators And Witnesses Say At Hearing

Executive Summary

“Dietary supplements are among the most poorly regulated consumer products,” CSPI policy director tells Senate Manufacturing, Trade and Consumer Protection Subcommittee. Ranking member Blumenthal says scams won’t end soon. “We’re six months into this pandemic with no end in sight.”

You may also be interested in...



Senate Proponents For Tighter Supplement Industry Regulation Question FDA’s Food Programs Overhaul

“We are concerned that these changes could divert resources, funding, and attention from the supplement market at a time when it is needed more than ever,” Democrats Dick Durbin and Richard Blumenthal says in letter to FDA.

France Clamping Down On Unapproved COVID-19 Supplement Claims

France is warning consumers not to be taken in by unapproved health claims for food supplements related to treating or preventing COVID-19. The country's competition authority is clamping down on unscrupulous websites and companies offering "miracle" products for sale.

Sun Sets On California Firm: FTC Pandemic Fraud Complaint Follows Criminal Indictment

Golden Sunrise business owner Huu Tieu marketed a package of herbal mixtures branded “Emergency D-Virus Plan of Care” with claims to treat COVID-19, says FTC complaint. Tieu was indicted on criminal charges two weeks before FTC filed complaint.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel